Changes in platelet P-selectin and in plasma C-reactive protein in acute atherosclerotic ischemic stroke treated with a loading dose of clopidogrel

Journal of Thrombosis and Thrombolysis

Volumn 14, Issue 2, 2002, Pages 145-150

  Cha, Jae Kwan ^a   Jeong, Min Ho ^a   Lee, Kyung Mi ^a   Bae, Hae Rahn ^a   Lim, Yeong Jin ^a   Park, Kyung Won ^a   Cheon, Sang Myung ^a  

^a Dong A University   (South Korea)

Author keywords

Clopidogrel; Ischemic stroke; P selectin

Indexed keywords

ACETYLSALICYLIC ACID; C REACTIVE PROTEIN; CHOLESTEROL; CLOPIDOGREL; HEMOGLOBIN A1C; HEPARIN; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR; LOW DENSITY LIPOPROTEIN CHOLESTEROL; PADGEM PROTEIN; TRIACYLGLYCEROL;

ADULT; AGED; ARTICLE; BRAIN ATHEROSCLEROSIS; BRAIN HEMORRHAGE; CELL SURFACE; CEREBROVASCULAR ACCIDENT; CLINICAL TRIAL; COMBINATION CHEMOTHERAPY; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DETERIORATION; DISEASE SEVERITY; DOSE RESPONSE; DOWN REGULATION; DRUG EFFICACY; DRUG SAFETY; FEMALE; GASTROINTESTINAL HEMORRHAGE; HEART INFARCTION; HUMAN; INFLAMMATION; MAJOR CLINICAL STUDY; MALE; NATIONAL INSTITUTE OF HEALTH STROKE SCALE; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; PROTEIN EXPRESSION; PROTEIN SYNTHESIS REGULATION; RANDOMIZED CONTROLLED TRIAL; SCORING SYSTEM; STATISTICAL ANALYSIS; THROMBOCYTE ACTIVATION;

AGED; ARTERIOSCLEROSIS; ASPIRIN; BLOOD PLATELETS; BRAIN ISCHEMIA; C-REACTIVE PROTEIN; CEREBROVASCULAR ACCIDENT; DRUG THERAPY, COMBINATION; FEMALE; HUMANS; MALE; MIDDLE AGED; P-SELECTIN; PLATELET AGGREGATION INHIBITORS; TICLOPIDINE;

EID: 0038555365     PISSN: 09295305     EISSN: None     Source Type: Journal    
DOI: 10.1023/A:1023237029550     Document Type: Article

References (38)

1. Ross R. Mechanisms of disease: Atherosclerosis is an inflammatory disease. N Engl J Med 1999;340:115-126.
2. Hartl R, Scheuer L, Schmid-Shonbin GW, et al. Experimental antileukocyte interventions in cerebral ischemia. J Cereb Blood Flow Metab 1996;16:1108-1119.
3. Kim JS. Cytokines and adhesion molecules in stroke and related diseases. J Neurol Sci 1996;137;69-78.
4. Silvestrini M, Pietroiusti A, Troisi E, et al. Leukocyte count and aggregation during the evolution of cerebral ischemic injury. Cerebrovasc Dis 1998;8:305-309.
5. Vila N, Castillo J, Davalos A, et al. Proinflammatory cytokines and early neurological worsening in ischemic stroke. Stroke 2000;31:2325-2329.
6. Castellanos M, Castillo J, Garcia MM, et al. Inflammation-mediated damage in progressing lacunar infarctions: A potential therapeutic target. Stroke 2002;33:982-987.
7. Berk BC, Weintraub WS, Alexander RW. Elevation of C-reactive protein in active coronary artery disease. J Am Cardiol 1990;65:168-172.
8. Tohgi H, Konno S, Takahashi S, et al. Activated coagulation/fibrinolysis system platelet function in acute thrombotic stroke patients with increased C-reactive protein levels. Thromb Res 2000;100:373-379.
9. Di Napoli M, Papa F, Bocola V. C-reactive protein in ischemic stroke: An independent prognostic factor. Stroke 2001;32:917-924.
10. Muir KW, Weir CJ, Alwan W, et al. C-reactive protein and outcome after ischemic stroke. Stroke 1999;30:981-985.
11. Neumann F-J, Marx N, Gawaz M, et al. Induction of cytokine expression in leukocytes by binding of thrombin-stimulated platelets. Circulation 1997;95:2387-2394.
12. McEver RP. A receptor for neutrophils and monocytes on activated platelets and endothelium. J Cell Biochem 1991;45:156-161.
13. McEver RP. The clinical significance of platelet membrane glycoproteins. Hematol Oncol Clin Am 1990;4:87-103.
14. Kirschenbaum LA, Adler D, Astiz ME, et al. Mechanisms of platelet-neutrophil interactions and effects on cell filtration in septic shock. Shock 2002;17:508-512.
15. Suzuki H, Hayashi T, Tojo SJ, et al. Anti-P-selectin antibody attenuates rat brain ischemic injury. Neurosci Lett 1999;265:163-166.
16. Suzuki H, Abe K, Tojo SJ, et al. Reduction of ischemic brain injury by anti-P-selectin monoclonal antibody after permanent middle cerebral artery occlusion in rat. Neurol Res 1999;21:269-276.
17. Zeller JA, Tschoepe D, Kessler C. Circulating platelets shows increased activation in patients with acute cerebral ischemia. Thromb Haemost 1999;81:373-377.
18. Yamazaki M, Uchiyama S, Iwata M. Measurement of platelet fibrinogen binding and P-selectin expression by flow cytometry in patients with cerebral infarction. Thromb Res 2001;104:197-205.
19. Gurbel PA, O'Connor CM, Dalesandro MR, et al. Relation of soluble and platelet P-selectin to early outcome in patients with acute myocardial infarction after thrombolytic therapy. Am J Cardiol 2001;87:774-777.
20. Cha J-K, Jeong M-H, Kim E-K, et al. Surface expression of P-selectin on platelets is related with clinical worsening in acute ischemic stroke. J Kor Med Sci 2002;17:801-806.
21. Savi P, Artcanuthurry V, Bornia J, et al. Effect of clopidogrel treatment on ADP-induced phosphorylations in rat platelets. Br J Haematol 1997;97:185-191.
22. Moshfegh K, Redondo M, Julmy F, et al. Antiplatelet effects of clopidogrel compared with aspirin after myocardial infarction: Enhanced inhibitory effects of combination therapy. J Am Coll Cardiol 2000;36:699-705.
23. Mehta SR, Yusuf S, Peters RJ, et al. Effects of pretreatment with clopidogrel and aspirin followed by long-term therapy in patients undergoing percutaneous coronary intervention: The PCI-CURE study. Lancet 2001;358:527-533.
24. Mehta SR, Yusuf S. The clopidogrel in unstable angina to prevent recurrent events (CURE) study investigators. The Clopidogrel in Unstable angina to prevent Recurrent Events (CURE) trial programme; Rationale, design and baseline characteristics including a meta-analysis of the effects of thienopyridines in vascular disease. Eur Heart J 2000;21:2033-2041.
25. Goldstein LB, Samsa GP. Reliability of the National Institutes of Health Stroke Scale. Extension to non-neurologists in the context of a clinical trial. Stroke 1997;28:307-310.
26. Inoue T, Sohma R, Miyazaki T, Iwasaki Y, Yaguchi I, Morooka S. Comparison of activation process of platelets and neutrophils after coronary stent implantation versus balloon angioplasty for stable angina pectoris. Am J Cardiol 2000;86:1057-1062.
27. Heesch CM, Wilhelm CR, Ristich J, Adnane J, Bontempo FA, Wagner WR. Cocaine activates platelets and increases the formation of circulating platelet containing microaggregates in humans. Heart 2000;83:688-695.
28. Masuhr, Einhaupl K. Treatment of ischemic stroke. Thromb Haemost 1999;82(suppl 1):85-91.
29. Grau AJ, Hacke W. Is there still a role for intravenous heparin in acute stroke? Yes. Arch Neurol 1999;56:1159-1160.
30. Adams HP Jr. Emergent use of anticoagulation for treatment of patients with ischemic stroke. Stroke 2002;33:856-861.
31. Weyrich AS, McIntyre TM, McEver RP, et al. Monocyte tethering by P-selectin regulates monocyte chemotactic protein-1 and tumor necrosis factor-alpha secretion. Signal integration and NF-kappa B translocation. J Clin Invest 1995;95:2297-2303.
32. Klinkhardt U, Graff J, Harder S. Clopidogrel, but not abciximab, reduces platelet leukocyte conjugates and P-selectin expression in a human ex vivo in vitro model. Clin Pharmacol Ther 2002;71:176-185.
33. Leimbach ME, Peyrou V, Marzec UM, et al. Single dose clopidogrel inhibition of adenosine receptor function in patients with atherosclerotic coronary artery disease (abstr). Circulation 1999;100:I-681.
34. Seyfarth HJ, Koksch M, Roethig G, et al. Effect of 300- and 450-mg clopidogrel loading doses on membrane and soluble P-selectin in patients undergoing coronary stent implantation. Am Heart J 2002;143:118-123.
35. Herbert JM, Dol F, Bernat A, Falotico R, et al. The anti-aggregating and antithrombotic activity of clopidogrel is potentiated by aspirin in several experimental models in the rabbit. Thromb Haemost 1998;80:512-518.
36. Westhuyzen J, Healy H. Review: Biology and relevance of C-reactive protein in cardiovascular and renal disease. Ann Clin Lab Sci 2000;30:133-143.
37. Feldman M, Jialal I, Devaraj S, et al. Effects of low-dose aspirin on serum C-reactive protein and thromboxane B2 concentrations: A placebo-controlled study using a highly sensitive C-reactive protein assay. J Am Coll Cardiol 2001;37:2036-2041.
38. Ikonomidis I, Andreotti F, Economou E, et al. Increased proinflammatory cytokines in patients with chronic stable angina and their reduction by aspirin. Circulation 1999;100:793-798.